Astellas taps Roska for consumer OAB product launch
August 08 2012
The agency announced the win Tuesday, just over a month after the FDA approval for extended-release tablet Myrbetriq.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.